The Hindu Business Line : Draft notification on standardisation of drugs issued

THE Ministry of Health and Family Welfare today issued a notification to amend Schedule M to the Drugs and Cosmetics Act to achieve uniform standardisation and production of quality drugs.

This pertains to Good Manufacturing Practices and requirements of premises, plant and equipment to be followed by the drug manufacturers. It has sought comments from the public within 30 days of the publication of the notification.

This Schedule that was earlier amended prescribed detailed guidelines for requirements for production of different pharmaceuticals for maintenance of quality control in the production of drugs through appropriate methodology, assistance procedures and documentation.

More Stories on : Standards & Benchmarks | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
No plans for berth on RIL board now: LIC chief
`Crisis will not impact investments'

India Inc heads optimism chart again, says survey

Service area norms for banks, RRBs relaxed

TRAI seeks more powers to resolve interconnect rows

SEBI amends listing pact terms to benefit investors

Sugar, hotel stocks make gains; HLL, Hindalco down

Draft notification on standardisation of drugs issued